Management of cellulitis in a pediatric emergency department

Pediatr Emerg Care. 2007 Nov;23(11):805-11. doi: 10.1097/PEC.0b013e31815a032f.

Abstract

Objectives: (1) To determine antibiotic choices, route of administration, and outcomes of children treated as outpatients with noncomplicated, nonfacial cellulitis at a tertiary care center. (2) To determine the number of visits and time spent in the emergency department (ED) for treatment.

Design: A descriptive case-control study.

Setting: A tertiary care pediatric ED at an academic medical center.

Methods: Medical records of all otherwise healthy children (aged 1-16 yrs) presenting with noncomplicated, nonfacial cellulitis over a 3-year period (January 1, 2001-December 31, 2003) were reviewed. Data extracted included the following: demographics; clinical presentation; laboratory and microbiology results; management, including choice, dose, and route of antibiotic(s); treatment failures; and time spent in the ED.

Interventions: None.

Main results: Two hundred sixty-nine patients met the inclusion criteria, and their charts were selected for review. The oral antibiotic most often prescribed was cephalexin (N = 105). Treatment failure occurred in 10 (8.9%) of the cases. The intravenous antibiotic most often prescribed was cefazolin (N = 124; 39 received cefazolin alone, and 85 received cefazolin and probenecid). The cefazolin-only group had 12 (31%) treatment failures, whereas the cefazolin and probenecid group had 7 (8.1%) treatment failures. More time in the ED (521 +/- 287 minutes) and more visits (3.4 +/- 2.8) were seen in the intravenous group as compared with the oral group (time in ED, 164 +/- 139 minutes; visits, 1.4 +/- 1).

Conclusions: Noncomplicated, nonfacial cellulitis is most commonly treated using first-generation cephalosporins. Treatment with oral antibiotics was effective and required fewer visits and less time in the ED compared with intravenous treatment. Twice-daily cefazolin and probenecid was associated with less treatment failures and admissions than cefazolin alone and may represent a reasonable alternative for children with nonfacial cellulitis requiring intravenous antibiotics.

MeSH terms

  • Academic Medical Centers
  • Adjuvants, Pharmaceutic / therapeutic use
  • Administration, Oral
  • Adolescent
  • Anti-Bacterial Agents / therapeutic use*
  • British Columbia / epidemiology
  • Case-Control Studies
  • Cefazolin / therapeutic use
  • Cellulitis / drug therapy*
  • Cellulitis / epidemiology
  • Cellulitis / microbiology
  • Cephalexin / therapeutic use
  • Child
  • Child, Preschool
  • Cloxacillin / therapeutic use
  • Emergency Service, Hospital / statistics & numerical data*
  • Female
  • Humans
  • Infant
  • Infusions, Intravenous
  • Male
  • Patient Admission / statistics & numerical data
  • Probenecid / therapeutic use
  • Retrospective Studies
  • Staphylococcus aureus / isolation & purification
  • Streptococcus pyogenes / isolation & purification

Substances

  • Adjuvants, Pharmaceutic
  • Anti-Bacterial Agents
  • Cefazolin
  • Cloxacillin
  • Cephalexin
  • Probenecid